Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City
May 09 2019 - 8:31AM
Business Wire
Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune
therapeutics company, today announced that the company will
participate in two upcoming healthcare conferences taking place in
New York City during May.
On Thursday, May 16, 2019, members of Gamida Cell’s management
team will participate in investor meetings at the Oppenheimer &
Co. Oncology Insight Summit.
Additionally, Julian Adams, Ph.D., chief executive officer of
Gamida Cell, will participate in a “fireside chat” at the RBC
Capital Markets Global Healthcare Conference on Tuesday, May 21,
2019, at 11:00 a.m. ET. A live webcast of the presentation will be
available on the Investors section of the Gamida Cell website,
www.gamida-cell.com.
About Gamida CellGamida Cell is a clinical-stage
biopharmaceutical company committed to developing advanced cell
therapies with the potential to cure blood cancers and rare,
serious hematologic diseases. We are leveraging our proprietary
nicotinamide-based, or NAM-based, cell expansion technology to
develop product candidates designed to address the limitations of
cell therapies. For additional information, please visit
www.gamida-cell.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190509005112/en/
Jaren Irene Maddenjaren@gamida-cell.com617-892-9084
Krystle Gibbs
(media)krystle@tenbridgecommunications.com508-479-6358
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Apr 2023 to Apr 2024